NCT03413124View on ClinicalTrials.gov

Bioavailability Study of MGL-3196 Tablets Compared to Capsules

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

February 17, 2018

Study Completion Date

March 13, 2018

Conditions
Healthy
Interventions
DRUG

MGL-3196 Tablet

MGL-3196 in Tablet form

DRUG

MGL-3196 Capsule

MGL-3196 in Capsule form

Trial Locations (1)

85283

Celerion, Tempe

Sponsors

Collaborators (1)

Celerion
All Listed Sponsors
collaborator

Celerion

INDUSTRY

lead

Madrigal Pharmaceuticals, Inc.

INDUSTRY

NCT03413124 - Bioavailability Study of MGL-3196 Tablets Compared to Capsules | Biotech Hunter | Biotech Hunter